St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Mary Powers
Mary Powers is a former member of the Strategic Communications, Education and Outreach Department at St. Jude Children’s Research Hospital.
Stories by Mary Powers
Research homes in on drug to dampen inflammation fueling life-threatening immune disorder
Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.
Histiocytic disorders are the focus of annual meeting at St. Jude
Read how clinical experts and researchers are trying to shed some light on histiocytic disorders, which are both extremely rare and difficult to diagnose.
The beginning of the end for the annual flu shot?
Researchers researching a flu vaccine that lasts longer and protects the most vulnerable patients.
Rare childhood disorders widen window on diseases of aging
Read how extremely rare genetic childhood diseases offer clues about understanding neurodegenerative disorders common with aging.
Lando: Star Wars smuggler or possible ally against Alzheimer’s disease?
High science calls on Star Wars character as a potential ally against Alzheimer’s disease.
Life after cancer: Researchers work to understand and ease the cognitive challenges that childhood cancer survivors face
Childhood cancer treatment is one of the great medical successes of recent decades. But that success comes with a price.
CAR T cells: Are they on the horizon for treatment of solid tumors?
Ongoing research on CAR T-cell therapy, heralded as a miracle cure, shows promise for treating solid tumors. How close are we?
The St. Jude Equations: A better method of calculating kidney function
Learn about new equations to estimate kidney function in young cancer patients more quickly and accurately.
Why does the risk of pediatric acute lymphoblastic leukemia relapse vary by race?
These inherited gene variations may help explain why the risk of relapse for children with acute lymphoblastic leukemia varies by race.